|
 biomarkers to patients
High-Throughput Cellular Profiling
Test your drug and drug combinations against the largest commercially available cancer cell line panel with advanced robotics and processes to guarantee high quality data with multiplexed end points available.
Genomic Biomarker Discovery
Leverage the world’s largest collection of curated cancer genomic data to identify biomarkers of drug sensitivity and resistance by combining gene expression, DNA copy number and tumor mutation data.
Stratify Likely Responders
Map your sensitive and resistant biomarkers to identify specific patient populations mostly likely to respond or not respond to your drug therapy based upon genomic profiles of 39,000+ reference patients.
CHALLENGE #1: Biomarker Discovery
- Multiple genomic data types and sources
- Gene expression
- DNA copy number
- Mutations
- Integrated & standardized from multiple sources
- Multiple potential analysis strategies
CHALLENGE #2: Predicting Patient Populations
- Is the biomarker discovered in cell lines relevant to clinical tumor populations?
- What is the prevalence of the biomarker in patients?
- How to apply multiplex genomic biomarkers in a clinical setting?
The OncoPredictor Solution combines the expertise of two market leaders.
Ricerca Biosciences
> A global, preferred provider of discovery and development services
> Providers of OncoPanel™
Compendia Bioscience
> Leaders in the field of cancer genomic data collection and analysis
> Providers of Oncomine™
For more information, please direct inquiries to  sales@compendiabio.com.
|
MORE